|
Volumn 61, Issue 6, 2001, Pages 810-814
|
Improved outcome in HIV/AIDS related multidrug-resistant tuberculosis patients treated with highly active antiretroviral therapy
a a a a a a |
Author keywords
AIDS; Anti retroviral therapy; HAART; Multidrug resistant tuberculosis
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CLOFAZIMINE;
CYCLOSERINE;
ETHAMBUTOL;
INDINAVIR;
ISONIAZID;
KANAMYCIN;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
OFLOXACIN;
PROTEINASE INHIBITOR;
PROTIONAMIDE;
PYRAZINAMIDE;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
STREPTOMYCIN;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARGENTINA;
ARTICLE;
CLINICAL OBSERVATION;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HELPER CELL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HOSPITAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
MICROSCOPY;
MORTALITY;
MULTIDRUG RESISTANCE;
PROSPECTIVE STUDY;
SPUTUM SMEAR;
SURVIVAL TIME;
TUBERCULOSIS;
VIRUS LOAD;
AIDS RELATED COMPLEX;
METHODOLOGY;
PROGNOSIS;
QUALITY OF LIFE;
RETROSPECTIVE STUDY;
SURVIVAL;
TIME;
TREATMENT OUTCOME;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
FEMALE;
HUMANS;
MALE;
PROGNOSIS;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
EID: 0035697453
PISSN: 00257680
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (18)
|